Ptc Therapeutics, Inc. · NASDAQ:PTCT

Klein Matthew B. sold 12,572 Ptc Therapeutics, Inc. shares (Form 4)

Traded May 13 to May 14, 2026 · Filed May 15, 2026

From May 13 to May 14, 2026, Klein Matthew B. (Director, CHIEF EXECUTIVE OFFICER) sold 12,572 Ptc Therapeutics, Inc. shares at an average US$72.95 for US$917K under a trading plan, leaving 393,998 shares. Filed May 15, 2026 (Form 4).

Sold
12,572 shares
Price
US$72.95 average (US$72.46 to US$73.08)
Value
US$917K
Holding after
393,998 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockAward12,500406,570Direct
May 14, 2026Common StockSale679US$73.06405,891Direct
May 14, 2026Common StockSale7,221US$73.08398,670Direct
May 14, 2026Common StockSale2,100US$73.08396,570Direct
May 14, 2026Common StockSale2,572US$72.46393,998Direct

Source

View original at SEC

Related